___

• Weisburger JH. Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 1999; 220 (4): 271-75.
• Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. [Abstract]. Ann Intern Med 1996; 125 (5): 384-89.
• Kritz H, Sinzinger H. Tea consumption, lipid metabolism, and atherosclerosis. [Abstract]. Wien Klin Wochenschr 1997; 109 (24): 944-48.
• Hollman PC, Feskens EJ, Katan MB. Tea flavonols in cardiovascular disease and cancer epidemiology. [Abstract]. Proc Soc Exp Biol Med. 1999; 220 (4): 198-202.
• Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998; 20: 237-48.
• Middleton ER. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998; 439: 175-82.
• Bohm H, Boeing H, Hempel J, Raab B, Krodke A. Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases. [Abstract]. Z Ernahrungswiss 1998; 37 (2): 147-63.
• Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 1997; 8 (10): 645-49.
• da Luz PL, Serrano Junior CV, Chacra AP, Monteiro HP, Yoshida VM, Furtado M, Ferreira S, Gutierrez P, Pileggi F. The effect of red wine on experimental atherosclerosis: lipid-independent protection. Exp Mol Pathol 1999; 65 (3): 150-59.
• Prior RL, Cao G. Antioxidan capacity and polyphenolic components of teas. Proc Soc Exp Biol Med 1999; 220 (4): 255-61.
• Beecher GR, Warden BA, Merken H. Analysis of tea polyphenols. Proc Soc Exp Biol Med 1999; 220 (4): 267-70.
• Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56 (11): 317-33.
• Carcia-Closas R, Agudo A, Gonzalez CA, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 1998; 32 (3): 154-58.
• Işıksoluğu MK. Kahve ile serum lipitleri ve koroner kalp hastalığı arasındaki ilişkiler. Gıda Dergisi 1994; 19 (5) : 323-28.
• Işıksoluğu MK. Kafein ve kan basıncı. F.Ü. Sağlık Bil Dergisi 1994; 8 (1): 118-124.
• Hara Y. The effects of tea polyphenols on cardiovascular diseases. Prevent Med 1992; 21: 333 A.
• Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Brit J Nutr 1997; 78: 41-48
• Imai K, Nakachi K. Cross sectional study of effects on drinking green tea on cardiovascular and liver diseases. Brit Med J 1995; 310: 693-97.
• Işıksoluğu MK. Kan basıncı ile vücut ağırlığı ve beslenme alışkanlığı arasındaki ilişkiler. Türk Hij Den Biyol Dergisi 1996; 53: 25-29.
• Rakic V, Beilin LJ, Burke V. Effect of coffee and tea drinking on postprandial hypotension in older men and women. Clin Exp Pharmacol Physiol 1996; 23 (6-7): 559-63.
• Kark CD, Friedlander Y, Kaufman NA, Stein Y. Coffee, tea and plasma cholesterol. The Jerusalem Lipid Research Clinic Prevalense Study. Br Med J 1985; 291: 699.
• İlhan N, Sondaç Ü, Özdemir Y, Işıksoluğu M. (1992). Kan lipitleri ile vücut ağırlığı, yaş, cinsiyet, çay ve sigara arasındaki ilişkiler. Doğa, Tr. J. of Medical Sciences. 1992; 16: 468-74.
• Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.[Astract]. Photochem Photobiol 1999; 69 (2): 148-53.
• Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women Am J Epidemiol 1999; 15; 149 (10): 943-49.
• Aucamp J, Gazpar A, Hara Y, Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res 1997; 17(6D): 4381-5.
• Vinson JA. Flavonoids in foods as in vitro and in vivo autioxidants. Adv Exp Med Biol 1998; 439: 151-64.
• van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB. Consumption of green or black tea does not increase resistance of low-density lipopratein to oxidation in humans. Am J Clin Nutr 1997; 66 (59): 1125-32.
• Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayari M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H. Effect of tea flavonid supplementation on suspectibilty of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997; 66 (2): 261-66.
• van het Hof KH, Wiseman SA, Tijburg LB. Plasma and lipoprotein levels of tea catechins following repeated tea consumption of green or black tea does not increase resistance of low-density lipopratein to oxidation in humans. Am J Clin Nutr 1997; 66 (59): 1125-32.
• Klatsky AL, Petitti DB, Armstrong MA, Friedman GD. Coffee, tea and cholesterol. Am J Cardiol 1985; 55: 577-82.
• Klatsky AL, Armstrong MA, Friedman GD. Coffee use prior to myocardial infarction restudied: Heavier intake may increase the risk. Am J Epidemiol 1990; 132 (3): 479.
• Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H. Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. [Abstract]. J Epidemiol Community Health 1993; 47 (3): 171-5
• Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: [Abstract]. the Caerphilly Study. Abst. Am J Clin Nutr 1997; 65 (5): 1489-94. 34.
• Sesso H, Gaziano M, Burung JE and Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J of Epidemiol 1999; 149: 162-67.
• Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. [Abstract]. J Clin Lab Anal 1997; 11 (5) : 287-313.